« VV Show #23 - Randy Komisar of Kleiner Perkins Caufield & Byers | Main | VV Show #25 - Jason Fried and Joel Spolsky Win Venture Voice Entrepreneurial Achievement Awards »

VV Show #24 - Bo Peabody of Village Ventures

Download the MP3.

Bo Peabody

“Stock lockup” is a term remembered with horror by many entrepreneurs who weren’t allowed to sell their dot com shares before the bubble burst. Bo Peabody founded Tripod, which was sold to Lycos for $58 million in stock. The terms of the sale forced him to hold onto his stock for two years -- while its value happened to increase ten-fold. He also happened to sell his shares just two months before the bubble burst. This lesson in luck was not lost on Bo, who wrote a book titled Lucky or Smart? However, his luck didn’t come out of nowhere. In our interview, he describes the years he spent developing his business even before the Internet was commercially available. He’s now helping entrepreneurs build businesses in parts of the country where venture capitalists typically don’t tread through his venture firm named Village Ventures.

Show notes:

2:15 Starting Tripod during college


4:45 Starting a .com without a technical background
  • “Business is fundamentally about getting other people to do what you want them to do.”
  • “If you’re an entrepreneur you need to be a B student in a lot of things.”
  • Team started with Ethan Zuckerman

6:25 Choosing a team
  • “We actually, as a rule, didn’t hire computer science majors.”

8:45 Operating out of Williamstown, Mass.

11:30 Becoming a success

12:15 Where the homepage builder idea came from

13:30 Getting the word out

  • “If there was one part of it that I regret, it was that both the press and me worked a little bit to make it [entrepreneurship] seem easier than it was.”
  • “It was harder than how we promoted it.”

18:00 Life at Lycos
  • Tripod was acquired by Lycos

19:30 When to sell the stock

20:40 Dilution

  • “When someone wants to put money into your company at a fair price you should take as much as you can get, because you never know when the market is going to turn.”

21:45 Next step

25:00 Starting businesses outside of major markets

28:30 Is venture capital still necessary to tech companies?

30:35 Google’s and Yahoo’s early aqusitions

32:00 Giving up equity

  • “The right place to start is to look to give up 25% to 35%” in an A round.

34:20 Pitching to Village Ventures
  • Make a business plan
  • Excerpt an executive summary
  • Try to get an introduction

37:15 Transitioning from entrepreneur to venture capitalist
  • “The only time I miss [being an entrepreneur] is when I’m involved with a company where I look at the CEO and say ‘God, I know I could do a better job than him or her.'”

39:15 Luck in business
  • “If you recognize luck then it humbles you a little bit.”

40:10 Entrepreneurial advice
  • “Technology does more in 10 years and less in 2 years than we think it’s going to.”

Posted by Greg Galant on Jan 17, 2006 | Permalink | Comments (6) | TrackBack (0)

Trackback Pings

TrackBack URL for this entry:
http://www.radiotail.com/cgi-bin/mt/mt-tb.cgi/178

Comments

Greg,
Thanks for the shout out and nice job bringing up questions about Joel and PG's ideas. Though Bo was dismissive of the competition for VC represented by early acquisition, I wonder if bootstrapping could prove to be a much bigger siphon of potential deals.

-Alex

Posted by: Alex at January 18, 2006 5:01 PM

Great podcast! Alex, I commented on this very question (VC vs. bootstrap) over at my blog at www.billbither.com.

Posted by: Bill Bither at January 19, 2006 12:51 AM

A very insightful interview.

Posted by: Oscar at January 21, 2006 2:28 AM

Excellent interview Greg! I use your interviews as weekly curriculum for my team. Thanks for the amazing work you do!

Posted by: Dhrumil at January 30, 2006 12:06 AM

Our group – Doctor of pharmaceutical Sciences, professor, academician Vajha Eriashvili, Laureate of state premium, doctor of medical sciences, professor Alexander Tsalughelashvili, engineer and economist David Gigolashvili, - decided to build Facility producing intervene IVPC solutions that meet the US FDA (GMP) standards in Georgia. We established “777” LTD company, which is registered in Tbilisi, 24th of December 1998 year, 20643846.

With that end in view we carry on negotiations with East-West Medical Agency (EWMA) as they can supply us with technologies, project of equipments and systems that meet the GMP&ISO 9002 standards.

Our Facility’s design is the latest in State-of-the Art manufacturing technology and is built to be more flexible in its production capacities, and to enhance the quality of the environment in which Iv Solutions are produced. Better controlled, cleaner environment, better, safer products!

Production of IVPC is very actual in Georgia. Technological presses offered by European IVPC producers don’t meet the standards of clean environment (class 100) that is required by US FDA standards. Nowadays IVPC production and realization is possible neither in Georgia nor in European and UIS (Union of Independent States) countries.

IVPC demand in US and Canada is 4 L. per inhabitant every year, 3,5 L in Europe, in Georgia according to World Organization of Health is needed no less than 1 L. IPVC.

In this project it is also foreseen preparation of cadres in US according to US FDA (GMP) demands.

IVPC Facility are designed and built to meet the US FDA (GMP) extremely stringent quality standards, which are acceptable worldwide. Therefore, the product manufactured by our Facility can be marked on a global scale.

None of the Facilities built by European companies can offer the same.

As you can see IVPC Facility, no matter what production configuration you choose, offer the highest cost effectiveness (capital outlay per one unit of production capability ratio) and therefore the highest and fastest return on investment.

In general, it is well known fact that the level of medicine practiced in the United States and medical products used in US are superior to most European countries because of the high standards, strict requirements and stringent regulations the US Government through its FDA imposes on medical industry. All these quality are reflected in the products our industry manufactures and offers.

We inform that Government consider the realization of project of IVPC advisable and they are ready to help us. According to above-mentioned the building of IVPC producer Facility that meet the GMP standards is very important and they are ready to discuss and carry on negotiations with investors about financing of this project.

Ladies and Gentlemen! We hope that you will discuss our project carefully and positively decide to help us in finding financial source for realization of this project.

Posted by: David Gigolashvili at March 7, 2006 3:59 PM

Great to hear what's happened to Bo Peabody over the years! I've been a fan for a long time!

Patty Seybold

Posted by: Patty Seybold at March 14, 2006 12:20 PM

Post a comment




Remember Me?

(you may use HTML tags for style)